SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-21-087656
Filing Date
2021-06-30
Accepted
2021-06-30 16:59:19
Documents
13

Document Format Files

Seq Description Document Type Size
1 424B4 tm2114556-19_424b4.htm 424B4 2856209
2 GRAPHIC lg_aerovate-4clr.jpg GRAPHIC 55916
3 GRAPHIC tm2114556d1-ph_normal4c.jpg GRAPHIC 143598
4 GRAPHIC tm2114556d1-lc_imatinib4c.jpg GRAPHIC 111076
5 GRAPHIC tm2114556d1-fc_medicationbw.jpg GRAPHIC 89923
6 GRAPHIC tm2114556d1-lc_lsmean4c.jpg GRAPHIC 121167
7 GRAPHIC tm2114556d1-tb_imati4c.jpg GRAPHIC 324988
8 GRAPHIC tm2114556d1-tb_place4c.jpg GRAPHIC 230598
9 GRAPHIC tm2114556d1-bc_meanbw.jpg GRAPHIC 110961
10 GRAPHIC tm2114556d1-lc_hours4clr.jpg GRAPHIC 112076
11 GRAPHIC tm2114556d1-lc_lungs4clr.jpg GRAPHIC 99486
12 GRAPHIC tm2114556d1-tb_adver4c.jpg GRAPHIC 235927
13 GRAPHIC tm2114556d1-tb_phase4c.jpg GRAPHIC 56677
  Complete submission text file 0001104659-21-087656.txt   5160586
Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-256949 | Film No.: 211062623
SIC: 2834 Pharmaceutical Preparations